Conference abstractPublished 30 Aug 2017
Study of Alternative Wilms tumor gene methylation as an epigenetic biomarker in acute myeloid Leukemia
Alexandria University, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Overexpression of the Wilms tumor 1 gene (WT1) is implicated in the prognosis of acute myeloid leukemia (AML) with high expression predicting disease progression, as well as being intensively studied as a potential molecular marker for minimal residual disease (MRD) and treatment response. Many different isoforms for WT1 are generated by alternative transcription initiation, mRNA splicing and alternative translation initiation. Recently, an alternative promoter incorporating a unique first exon, alternative WT1 transcript (AWT1), has been described. The AWT1 expression and the underlying epigenetic alterations associated with its expression in AML are still unknown.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGenetics & Molecular Biology
- SubjectHaematology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Reham Abo Elwafa”